A detailed history of Brown Advisory Inc transactions in Natera, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 4,828 shares of NTRA stock, worth $810,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,828
Previous 4,690 2.94%
Holding current value
$810,524
Previous $507,000 20.91%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$97.75 - $129.67 $13,489 - $17,894
138 Added 2.94%
4,828 $613,000
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $1,108 - $1,463
-13 Reduced 0.28%
4,690 $507,000
Q1 2024

Apr 24, 2024

BUY
$59.21 - $92.9 $1,657 - $2,601
28 Added 0.6%
4,703 $430,000
Q4 2023

Feb 08, 2024

SELL
$37.55 - $62.64 $2,365 - $3,946
-63 Reduced 1.33%
4,675 $292,000
Q3 2023

Oct 24, 2023

BUY
$43.4 - $62.52 $17,360 - $25,008
400 Added 9.22%
4,738 $209,000
Q1 2023

May 08, 2023

BUY
$36.57 - $58.29 $158,640 - $252,862
4,338 New
4,338 $240,000
Q2 2022

Aug 02, 2022

SELL
$28.13 - $44.54 $119,439 - $189,116
-4,246 Reduced 44.18%
5,365 $486,000
Q1 2022

Nov 14, 2022

BUY
$30.32 - $91.33 $221,093 - $665,978
7,292 New
7,292 $297,000
Q1 2022

May 09, 2022

SELL
$30.32 - $91.33 $10.1 Million - $30.5 Million
-333,932 Reduced 97.2%
9,611 $660,000
Q4 2021

Jan 27, 2022

BUY
$86.26 - $119.0 $23.7 Million - $32.6 Million
274,205 Added 395.46%
343,543 $32.1 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $6.69 Million - $8.44 Million
66,766 Added 2595.88%
69,338 $7.73 Million
Q2 2021

Jul 29, 2021

BUY
$86.05 - $119.72 $27,880 - $38,789
324 Added 14.41%
2,572 $292,000
Q1 2021

May 14, 2021

BUY
$91.47 - $124.36 $205,624 - $279,561
2,248 New
2,248 $228,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.